Brief: Euroespes says its vaccine against Alzheimer's approved by US patent office
Oct 17 (Reuters) - EUROESPES SA EESP.MC :
* SAYS ITS EB101 VACCINE AGAINST ALZHEIMER DISEASE APPROVED BY US PATENT OFFICE
Source text: http://bit.ly/2x1Xi2e
Further company coverage: EESP.MC
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Euroespes SA
See all newsBrief: Euroespes To Run Capital Increase Of 0.9 Mln Euros
Brief: Euroespes H1 Net Result Turns To Loss Of 0.5 Mln Euros YoY
Brief: Euroespes FY Net Result Turns To Loss Of 0.3 Mln Euros YoY
Brief: Moira Capital Subscribes For Euroespes' Shares For 4.6 Mln Euros
Brief: Euroespes H1 Net Profit Down At 7,485 Euros YoY